MDS World Awareness Day is October 25. Knowledge can help patients and caregivers feel more prepared. Explore HealthTree’s MDS Guide and upcoming educational webinars. 👉 Learn more: htree.org/mdsguide #MDSAwareness #MDS #HealthTree

Thank you @MeeraMohanMD for hosting the HealthTree Houston Roundtable to teach patients about new tools like bispecific antibodies in myeloma and how they are changing the outcomes for NDMM and RRMM. Such amazing progress that is so good for patients. #mmsm

@MeeraMohanMD shares new myeloma immunotherapy strategies like antibody drug conjugates, bispecific antibodies and CAR T at the HealthTree Houston Roundtable. #mmsm

CAR T in myeloma is a personalized, living therapy, timing and eligibility matter, preparation is key and lasting responses are possible. @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Patients can ask their doctor about CAR T eligibility. Am I a candidate? Do I need a referral to a CAR T center? Are there CAR T trials I should join? @DrKrinaPatel of MDACC at the HealthTree Houston Roundtable. #mmsm

Individualizing therapy in myeloma factors in genetics, frailty and comorbidities, patient outcomes, adapted treatment based on MRD status, toxicity, disease resistance, social factors and sequencing. Savari Yellqpragada, MD of MDACC. #mmsm

Frailty rather than age predicts outcomes in myeloma - Sarvari Yellqpragada, MD of MDACC at the Houston HealthTree Roundtable. Frail patients can limit induction, avoid transplant and de-escalate maintenance. #mmsm

“Assessing risk can be risky” says Bill Matsui, MD of MDACC. It’s statistical, not exact. Risk can change over time and each risk factor (genetics, disease stage, etc) may contribute differently for each myeloma patient. At the HealthTree Houston Roundtable #mmsm

Bill Matsui, MD of MD Anderson shares early precursor conditions and how newly diagnosed myeloma patients can find personalized care - today at the Houston HealthTree Roundtable. #mmsm

Join Dr. William G. Wierda, MD, PhD from MD Anderson for a live CLL CME on Nov. 17, 5–6 PM CT. Explore treatment strategies and shared decision-making for personalized care. activities.paradigmmc.com/14… @ParadigmMedCom @CllSociety #CME